» Articles » PMID: 17011140

In Atherogenesis, the Apoptosis of Endothelial Cell Itself Could Directly Induce Over-proliferation of Smooth Muscle Cells

Overview
Journal Med Hypotheses
Specialty General Medicine
Date 2006 Oct 3
PMID 17011140
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Over-proliferation of SMC (smooth muscle cell) is one characteristics of atherosclerosis. One well accepted mechanism is that the decrease of ECs (endothelial cells) induced by over apoptosis leads to endothelial dysfunction, which in turn results in over-proliferation of SMC. Obviously, the mechanism works after endothelial apoptosis. Compared with necrosis, apoptosis is time and energy consuming. The question is why the cell ends in the form of apoptosis instead of necrosis. From the evolutionary standpoint, apoptosis has some useful functions other than removing the damaged or unwanted cells. Recent studies showed that cells nearby the apoptotic ones began to proliferate and differentiate before apoptosis and the apoptotic signals could induce the near cells to proliferate without the death of cells. Apparently, some mechanism in apoptosis results in the proliferation of cells. So, we hypotheses that endothelial apoptosis can directly induce the over-proliferation of SMC.

Citing Articles

Regular transient limb ischemia improves endothelial function and inhibits endothelial cell apoptosis to prevent atherosclerosis in rabbit.

Zhang N, Wen Y, Li J, Zheng W, Jin S BMC Cardiovasc Disord. 2024; 24(1):209.

PMID: 38627625 PMC: 11020181. DOI: 10.1186/s12872-024-03869-0.


Comprehensive assessment of markers of apoptosis and cell proliferation during progression of atherosclerosis after surgery in patients with peripheral arterial disease.

Kalinin R, Suchkov I, Klimentova E J Vasc Bras. 2023; 22:e20220029.

PMID: 36794174 PMC: 9925059. DOI: 10.1590/1677-5449.202200292.


Therapeutic potential of paeoniflorin in atherosclerosis: A cellular action and mechanism-based perspective.

Yu W, Ilyas I, Hu X, Xu S, Yu H Front Immunol. 2023; 13:1072007.

PMID: 36618414 PMC: 9811007. DOI: 10.3389/fimmu.2022.1072007.


A review on therapeutical potential of paeonol in atherosclerosis.

Yu W, Ilyas I, Aktar N, Xu S Front Pharmacol. 2022; 13:950337.

PMID: 35991897 PMC: 9385965. DOI: 10.3389/fphar.2022.950337.


PLF-1 (Proliferin-1) Modulates Smooth Muscle Cell Proliferation and Development of Experimental Intimal Hyperplasia.

Hu L, Huang Z, Ishii H, Wu H, Suzuki S, Inoue A J Am Heart Assoc. 2019; 8(24):e005886.

PMID: 31838975 PMC: 6951060. DOI: 10.1161/JAHA.117.005886.